Transient RNA interference in hematopoietic progenitors with functional consequences

Genesis (United States)

Volumn 36, Issue 4, 2003, Pages 203-208

  Oliveira, Daniela M ^a   Goodell, Margaret A ^a  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

Electroporation; Hematopoietic; RNA; SiRNA; Stem cells

Indexed keywords

CD45 ANTIGEN; GENE PRODUCT; RETROVIRUS VECTOR; RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL TYPE; COLONY FORMATION; CONTROLLED STUDY; ELECTROPORATION; GENE CASSETTE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE ISOLATION; GENE TECHNOLOGY; GENETIC TRANSFECTION; HEMATOPOIESIS; KNOCKOUT GENE; MAMMAL; MARKER GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATOR GENE; RNA ANALYSIS; RNA INTERFERENCE; RNA TRANSFECTION; STEM CELL; VIRAL GENE DELIVERY SYSTEM;

GENETTA; MAMMALIA;

EID: 0042887572     PISSN: 1526954X     EISSN: None     Source Type: Journal    
DOI: 10.1002/gene.10212     Document Type: Article

References (22)

1. Becker A, Reith A, Napiwotzki J, Kadenbach B. 1996. A quantitative method of determining initial amounts of DNA by polymerase chain reaction cycle titration using digital imaging and a novel DNA stain. Anal Biochem 237:204-207.
2. Bradfute SB, Goodell MA. 2003. Adenoviral transduction of mouse hematopoietic stem cells. Mol Ther 7:334-340.
3. Brummelkamp TR, Bernards R, Agami R. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550-553.
4. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. 2001a. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498.
5. Elbashir SM, Lendeckel W, Tuschl T. 2001b. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15:188-200.
6. Eppich HM, Foxall R, Gaynor K, Dombkowski D, Miura N, Cheng T, Silva-Arrieta S, Evans RH, Mangano JA, Preffer FI, Scadden DT. 2000. Pulsed electric fields for selection of hematopoietic cells and depletion of tumor cell contaminants. Nat Biotechnol 18:882-887.
7. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806-811.
8. Guo S, Kemphues KJ. 1995. par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell 81:611-620.
9. Hanson P, Mathews V, Marrus SH, Graubert TA. 2003. Enhanced green fluorescent protein targeted to the Sca-1 (Ly-6A) locus in transgenic mice results in efficient marking of hematopoietic stem cells in vivo. Exp Hematol 31:159-167.
10. Hemann MT, Fridman JS, Zilfou JT, Hernando E, Paddison PJ, Cordon-Cardo C, Hannon GJ, Lowe SW. 2003. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat Genet 33:396-400.
11. Ivanova NB, Dimos JT, Schaniel C, Hackney JA, Moore KA, Lemischka IR. 2002. A stem cell molecular signature. Science 298:601-604.
12. Myers JW, Jones JT, Meyer T, Ferrell JE. 2003. Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing. Nat Biotechnol 21:324-328.
13. Penninger JM, Irie-Sasaki J, Sasaki T, Oliveira-dos-Santos AJ. 2001. CD45: new jobs for an old acquaintance. Nat Immunol 2:389-396.
14. Phillips RL, Ernst RE, Brunk B, Ivanova N, Mahan MA, Deanehan JK, Moore KA, Overton GC, Lemischka IR. 2000. The genetic program of hematopoietic stem cells. Science 288:1635-1640.
15. Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC, Melton DA. 2002. "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 298:597-600.
16. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, Zhang M, McManus MT, Gertler FB, Scott ML, Van Parijs L. 2003. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33:401-406.
17. Sohail M, Doran G, Riedemann J, Macaulay V, Southern EM. 2003. A simple and cost-effective method for producing small interfering RNAs with high efficacy. Nucleic Acids Res 31:e38.-
18. Spangrude GJ, Heimfeld S, Weissman IL. 1988. Purification and characterization of mouse hematopoietic stem cells. Science 241:58-62.
19. Sui G, Soohoo C, Affar el B, Gay F, Shi Y, Forrester WC. 2002. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci USA 99:5515-5520.
20. Terskikh AV, Easterday MC, Li L, Hood L, Kornblum HI, Geschwind DH, Weissman IL. 2001. From hematopoiesis to neuropoiesis: evidence of overlapping genetic programs. Proc Natl Acad Sci USA 98:7934-7939.
21. Trowbridge IS, Thomas ML. 1994. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol 12:85-116.
22. Zambrowicz BP, Imamoto A, Fiering S, Herzenberg LA, Kerr WG, Soriano P. 1997. Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc Natl Acad Sci USA 94:3789-3794.